ADMA Biologics Files 8-K on Other Events and Financial Exhibits
Ticker: ADMA · Form: 8-K · Filed: Feb 21, 2024 · CIK: 1368514
| Field | Detail |
|---|---|
| Company | Adma Biologics, Inc. (ADMA) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, other-events
TL;DR
**ADMA Biologics just filed a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' on Feb 21, 2024.**
AI Summary
ADMA Biologics, Inc. filed an 8-K on February 21, 2024, reporting on "Other Events" and "Financial Statements and Exhibits." The filing indicates that the company, incorporated in Delaware with IRS Employer Identification No. 56-2590442, maintains its principal executive offices at 465 State Route 17, Ramsey, New Jersey 07446. This 8-K serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing provides a routine update on ADMA Biologics' corporate activities, ensuring transparency for investors regarding any 'Other Events' or 'Financial Statements and Exhibits' as of February 21, 2024.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no specific details indicating new risks or significant changes.
Key Numbers
- 001-36728 — Commission File Number (SEC filing identifier)
- 201-478-5552 — Business Phone (Registrant's contact number)
- 20240221 — Filing Date (Date the 8-K was filed)
- 16 — Public Document Count (Number of public documents in the filing)
- 1934 — SEC Act Year (Year of the Securities Exchange Act)
Key Players & Entities
- ADMA BIOLOGICS, INC. (company) — Registrant
- Delaware (company) — State of incorporation
- 56-2590442 (dollar_amount) — IRS Employer Identification No.
- 465 State Route 17 , Ramsey , New Jersey 07446 (company) — Address of principal executive offices
- February 21, 2024 (date) — Date of earliest event reported
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is ADMA BIOLOGICS, INC.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 21, 2024.
Where are ADMA Biologics, Inc.'s principal executive offices located?
ADMA Biologics, Inc.'s principal executive offices are located at 465 State Route 17, Ramsey, New Jersey 07446.
What is the Commission File Number for ADMA Biologics, Inc.?
The Commission File Number for ADMA Biologics, Inc. is 001-36728.
Under which sections of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 427 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2024-02-21 08:00:18
Filing Documents
- ef20022054_8k.htm (8-K) — 27KB
- ef20022054_ex99-1.htm (EX-99.1) — 12KB
- image00001.jpg (GRAPHIC) — 4KB
- 0001140361-24-008680.txt ( ) — 181KB
- adma-20240221.xsd (EX-101.SCH) — 4KB
- adma-20240221_lab.xml (EX-101.LAB) — 22KB
- adma-20240221_pre.xml (EX-101.PRE) — 16KB
- ef20022054_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events On February 21, 2024, ADMA Biologics, Inc. issued a press release announcing the successful initial use of its Artificial Intelligence program, named ADMAlytics. A copy of the press release is attached as Exhibit 99.1 and incorporated by reference herein.
01
Item 9.01 Exhibits. (d) Exhibits Exhibit No. Description 99.1 ADMA Biologics, Inc. Press Release, dated February 21, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. February 21, 2024 ADMA Biologics, Inc. By: /s/ Brian Lenz Name: Brian Lenz Title: Executive Vice President and Chief Financial Officer